Standout Papers

Clonal hematopoiesis of indeterminate potential and ... 2006 2026 2012 2019 1.2k
  1. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes (2015)
    David P. Steensma, Rafael Bejar et al. Blood
  2. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients (2006)
    Animesh Pardanani, Ross L. Levine et al. Blood
  3. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations (2014)
    R. Coleman Lindsley, Brenton G. Mar et al. Blood
  4. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients (2014)
    Rafael Bejar, Allegra M. Lord et al. Blood
  5. Bone marrow niches in haematological malignancies (2020)
    Simón Méndez‐Ferrer, Dominique Bonnet et al. Nature reviews. Cancer

Immediate Impact

2 by Nobel laureates 7 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
The total mass, number, and distribution of immune cells in the human body
2023 Standout
7 intermediate papers

Works of David P. Steensma being referenced

Lymphadenopathy
2000
Lymphadenopathy
2000
and 9 more

Author Peers

Author Last Decade Papers Cites
David P. Steensma 8910 5775 4432 430 12.8k
Sergio Amadori 9706 3635 4055 359 15.2k
Robert K. Hills 9484 2838 5355 240 14.4k
Daniel J. DeAngelo 8805 3832 6062 438 15.9k
Bayard L. Powell 9461 2874 5629 256 13.9k
Ravi Bhatia 8749 4278 4683 453 21.2k
Mark R. Litzow 11567 4734 5368 585 18.3k
Alan F. List 15152 6419 8141 615 21.4k
Wendy Stock 5950 2245 3463 457 11.8k
François Guilhot 14255 10326 2910 347 18.0k
Gregory H. Reaman 3083 2649 4171 301 15.5k

All Works

Loading papers...

Rankless by CCL
2026